Abstract:Introduction Voxel based morphometry (VBM) is a neuroimaging analysis technique that allows investigation of focal differences in brain anatomy, using the statistical approach of so-called statistical parametric mapping [1,2]. Major depressive disorder (MDD) is a common and serious psychiatric illness. In past study, the authors have done many researches to reveal the change in grey matter [3-7]. However, the neurobiology of MDD is largely unknown. The purpose of the present study was to identify brain regions with gray matter volume and density changes with relative large MDD subjects and controls using optimized voxel-based morphometry. Material and Method Fifty one patients experiencing MDD (mean age = 34.6 ± 12.7, twenty five males and twenty eight females) according to the diagnostic criterion of DSM-IV, who had a score of 18 or greater on the 17-item Hamilton Depression Rating Scale (HAMD), and fifty two age and sex matched normal controls (mean age = 37.2 ± 16.1, twenty three males and twenty eight females) were recruited. MR scanning was carried out on a 3.0 TMR scanner (EXCITE, GE Signa, Milwaukee, USA). High resolution 3-dimensional T1-weighted (T1W) images were acquired employing a spoiled gradient recalled (SPGR) sequence with TR/TE = 8.5/3.4 ms, FA = 120, 156 axial slices with thickness = 1 mm, axial FOV 24 × 24 cm and data matrix = 256 × 256. Optimized voxel-based morphometry [2] was conducted using Statistical Parametric Mapping–2 (SPM2) (Welcome Department of Imaging Neuroscience, London [http://www.fil.ion.ucl.ac.uk/spm]). The voxel-based morphometry–2 toolbox, which implements the optimized voxel-based morphometry approach [2], was used for data preprocessing. Voxel-by-voxel-based comparisons of gray matter density and volume were performed between groups using two-sample t tests. The correlation between the regional gray matter changes and clinical symptom severity was examined. A corrected p value of less than 0.001 was deemed to be significant. Results Patients with MDD exhibited higher grey matter volume than normal controls in multiple brain regions including bilateral thalamus, left and right superior parietal lobule, right frontal lobe (Table 1, Figure 1 A, B and C). MDD patients also showed higher grey matter density than normal controls in bilateral thalamus (cluster level p < 0.001, corrected) (Table 1, Figure 1 D). No significant correlation between regional gray matter changes and HAMD scores was found after controlling for age, years of education and duration of illness.

Gray matter volume differences based on sex in first-episode drug-naive patients with major depressive disorder and its molecular analysis

565 – Abnormality of White Matter Structure and Resting State Brain Function in First-Episode, Treatment-Naive Patients with Major Depressive Disorder

Sex Differences in the Clinical Characteristics and Brain Gray Matter Volume Alterations in Unmedicated Patients with Major Depressive Disorder

Gray matter volume abnormalities were associated with sustained attention in unmedicated major depression.

Sex-specific alterations of cortical morphometry in treatment-naïve patients with major depressive disorder

Brain Grey Matter Abnormalities in Medication-Free Patients with Major Depressive Disorder: a Meta-Analysis

Gray matter volume alterations in first-episode drug-naïve patients with deficit and nondeficit schizophrenia

Changes of brain morphometry in first-episode, drug-naïve, non-late-life adult patients with major depression: an optimized voxel-based morphometry study.

Gender differences in major depressive disorders: A resting state fMRI study

Brain Grey Matter Volume Alterations Associated with Antidepressant Response in Major Depressive Disorder.

A voxel-based morphometric MRI study in middle-aged female patients with first-episode major depressive disorders

Gray Matter Volume Abnormalities in the Reward System in First-Episode Patients with Major Depressive Disorder.

Gray Matter Alterations in Adolescent Major Depressive Disorder and Adolescent Bipolar Disorder.

Gray Matter Abnormalities in Non-comorbid Medication-naive Patients with Major Depressive Disorder or Social Anxiety Disorder

Study of Sex Differences in Unmedicated Patients with Major Depressive Disorder by Using Resting State Brain Functional Magnetic Resonance Imaging.

Essential brain structural alterations in major depressive disorder: A voxel-wise meta-analysis on first episode, medication-naive patients.

Divergent effects of sex on hippocampal subfield alterations in drug-naive patients with major depressive disorder

Structural Neuroimaging and Molecular Signatures of Drug‐Naive Depression With Melancholic Features

Volumetric Deficit Within the Fronto-Limbic-Striatal Circuit in First-Episode Drug Naïve Patients With Major Depression Disorder

Convergent molecular and structural neuroimaging signatures of first-episode depression

Regional gray matter changes in major depressive disorder : an optimized voxel-based morphometry study